Rapid Reviews Infectious Diseases
RR\ID (Rapid Reviews\Infectious Diseases) is an open-access overlay journal that accelerates peer review of important infectious disease-related research preprints.
Latest preprint reviews
-
SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
This article has 7 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Nosocomial Pseudomonas aeruginosa regulates alginate biosynthesis and Type VI secretion system during adaptive and convergent evolution for coinfection in critically ill COVID-19 patients
This article has 12 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Preferential recognition and antagonism of SARS-CoV-2 spike glycoprotein binding to 3- O -sulfated heparan sulfate
This article has 7 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Multisystemic Cellular Tropism of SARS-CoV-2 in Autopsies of COVID-19 Patients
This article has 16 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Single-cell RNA Expression of SARS-CoV-2 Cell Entry Factors in Human Endometrium during Preconception
This article has 5 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021
This article has 18 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Modelling the impact of reopening schools in the UK in early 2021 in the presence of the alpha variant and with roll-out of vaccination against SARS-CoV-2
This article has 9 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2
This article has 5 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Sensing of COVID‐19 Antibodies in Seconds via Aerosol Jet Nanoprinted Reduced‐Graphene‐Oxide‐Coated 3D Electrodes
This article has 8 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Viral Variants and Vaccinations: If We Can Change the COVID-19 Vaccine… Should We?
This article has 1 author:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT